2024 End of Year Message
It’s been one year since we asked you to support the Alliance’s audacious effort to create our own research lab — the CCM CureDriver™ Lab — to test potential cavernous…
Patient Participation
CCM 101
CCM 101 is an informational meeting for new members offered on the first Thursday of the month, at 7:00 PM Eastern. We’ll review slides covering the basics of the illness…
Recursion CCM Drug Trial Breakthrough
Recursion’s SYCAMORE trial meets primary endpoint of safety and demonstrates encouraging trends in objective MRI-based exploratory efficacy measures SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading…
Impact Report 2023
Your generosity has made a difference! Get the full 2023 Impact Report here
